Injection of Renuva Allograft adipose matrix in vocal fold for Vocal Cord Paralysis
Study Summary
This trialwill see if Renuva, a filler used in cosmetic procedures, can be used as an injectable to treat vocal fold glottic insufficiency.
- Vocal Cord Paralysis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: 18 months
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Injection of Renuva Allograft adipose matrix in vocal fold
1 of 1
Experimental Treatment
50 Total Participants · 1 Treatment Group
Primary Treatment: Injection of Renuva Allograft adipose matrix in vocal fold · No Placebo Group · Phase 3
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Has the FDA sanctioned the utilization of Renuva Allograft adipose matrix injection for vocal fold treatment?
"There is extant clinical evidence affirming Injection of Renuva Allograft adipose matrix in vocal fold to be safe, thus it was scored a 3." - Anonymous Online Contributor
Are there any slots left in this research trial?
"Affirmative. Clinicaltrials.gov presents evidence that this clinical examination is presently recruiting participants, with the initial posting of May 16th 2022 and most recent update occurring February 2nd 2023. There are 50 vacancies across 1 location for potential test subjects." - Anonymous Online Contributor
How many participants are being recruited to join this medical experiment?
"Affirmative. According to clinicaltrials.gov, the trial was initially posted on May 16th 2022 and is now actively searching for participants. A total of 50 patients are required from one medical centre." - Anonymous Online Contributor